The role of TRPM7 in the lidocaine effect was confirmed in breast cancer cell line MDA-MB-231: the effect of lidocaine (0.3–1 mM) on viability and migration was reduced by the knockout of TRPM7 (Figure 6C,D). Here, TRPM7 is linked to breast carcinoma.